SleepCogni secures £463k in grant funding from Innovate UK for insomnia research
Innovate UK has backed the medical device firm to advance clinical trials and research.
SleepCogni is a medical technology company based in Sheffield that develops digital solutions for insomnia care. The firm combines clinical insights with advanced monitoring to improve patient outcomes.
SleepCogni has secured £463k in grant funding from Innovate UK to advance its research and development into insomnia treatments. The capital will support a clinical trial involving 150 subjects over 1,490 research nights, following previous investment from Mercia Fund Management.
The company is developing a bedside medical device that combines cognitive behavioural therapy and dynamic biofeedback to help users manage and resolve sleep problems. The fresh capital enables the organisation to expand its team and relocate to the Kroto Innovation and Research Centre at the University of Sheffield.
From the founder
"We are very excited about our current progress in research and development. Validation and further development is ongoing, and we are planning our clinical trials, in collaboration with scientists from both Universities in Sheffield and internationally, in the Netherlands. We are committed to use our technology to help people that suffer from issues related to sleep."
Maan Van de Werken
Chief Scientific Officer at SleepCogni
Investor perspective
"We are excited to be supporting what could potentially be a game changing patented technology, this is a global issue that is crying out for a clinical solution."
Ash Patel
Investment Manager, Mercia Fund Management
Use of funds
- 01Fund research and development
- 02Grow the team
- 03Scale operations
Investors
Categories
About the company
SleepCogni
SleepCogni builds digital technology to transform insomnia care and sleep health.